Quarterly report pursuant to Section 13 or 15(d)

ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.20.2
ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
 3 Months Ended
Mar. 31, 2020
Accounting Policies [Abstract]  
Schedule of changes in derivative liability

The following presents changes in the derivative liability:

 

    Quarter Ended   Quarter Ended
    March 31, 2020   March 31, 2019
Beginning Balance   $ 24,767,000     $ 11,917,000  
Conversion to note payable     (19,291,000 )        
(Decrease) increase in fair value recognized in earnings     (5,476,000 )     3,937,000  
Ending Balance   $ —       $ 15,854,000  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table presents: 1) instruments that were dilutive for the quarter ended March 31, 2020 and included in the diluted earnings per share, and 2) instruments that were anti-dilutive for the quarter ended March 31, 2019 and excluded from diluted earnings per share as they would have been antidilutive:

 

    Instruments Included in Diluted EPS March 31, 2020   Instruments Excluded in Diluted EPS March 31, 2019
Convertible notes and accrued interest     100,075,503       94,938,750  
Convertible preferred stock - Series B     11,818,181       11,818,181  
Warrants     —         —    
Compensation-based stock options and warrants     177,050,000       171,631,482